Alerts will be sent to your verified email
Verify Email
SAMRATPH
|
Samrat Pharmachem
|
Mercury Laboratories
|
Zenith Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.36 % | 10.51 % | 22.97 % |
|
5yr average Equity Multiplier
|
1.97 | 1.49 | 4.46 |
|
5yr Average Asset Turnover Ratio
|
2.61 | 1.05 | 1.16 |
|
5yr Avg Net Profit Margin
|
3.99 % | 6.6 % | 4.99 % |
|
Price to Book
|
1.46 | 1.94 | 0.0 |
|
P/E
|
14.71 | 33.14 | 11.67 |
|
5yr Avg Cash Conversion Cycle
|
59.17 Days | -4.69 Days | -99.3 Days |
|
Inventory Days
|
27.69 Days | 32.68 Days | 53.1 Days |
|
Days Receivable
|
78.39 Days | 115.65 Days | 141.66 Days |
|
Days Payable
|
45.36 Days | 157.73 Days | 298.39 Days |
|
5yr Average Interest Coverage Ratio
|
14.72 | 15.15 | 4.04 |
|
5yr Avg ROCE
|
30.03 % | 13.49 % | 30.01 % |
|
5yr Avg Operating Profit Margin
|
5.83 % | 11.74 % | 9.39 % |
|
5 yr average Debt to Equity
|
0.26 | 0.13 | 1.14 |
|
5yr CAGR Net Profit
|
-12.62 % | -10.08 % | 25.02 % |
|
5yr Average Return on Assets
|
10.58 % | 7.02 % | 5.56 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.09 % | 73.66 % | 69.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.56 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Samrat Pharmachem
|
Mercury Laboratories
|
Zenith Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|